Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife.

Descovich M, Carrara M, Morlino S, Pinnaduwage DS, Saltiel D, Pouliot J, Nash MB, Pignoli E, Valdagni R, Roach M 3rd, Gottschalk AR.

J Appl Clin Med Phys. 2013 Sep 6;14(5):162-72. doi: 10.1120/jacmp.v14i5.4333.

PMID:
24036869
2.

A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning.

Good D, Lo J, Lee WR, Wu QJ, Yin FF, Das SK.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):176-81. doi: 10.1016/j.ijrobp.2013.03.015.

PMID:
23623460
3.

Improved robotic stereotactic body radiation therapy plan quality and planning efficacy for organ-confined prostate cancer utilizing overlap-volume histogram-driven planning methodology.

Wu B, Pang D, Lei S, Gatti J, Tong M, McNutt T, Kole T, Dritschilo A, Collins S.

Radiother Oncol. 2014 Aug;112(2):221-6. doi: 10.1016/j.radonc.2014.07.009.

PMID:
25108808
4.

Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.

Rucinski A, Brons S, Richter D, Habl G, Debus J, Bert C, Haberer T, Jäkel O.

Radiat Oncol. 2015 Feb 27;10:56. doi: 10.1186/s13014-015-0348-1.

5.

Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.

Malone S, Croke J, Roustan-Delatour N, Belanger E, Avruch L, Malone C, Morash C, Kayser C, Underhill K, Li Y, Malone K, Nyiri B, Spaans J.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):725-32. doi: 10.1016/j.ijrobp.2011.12.081.

PMID:
22444999
6.

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.

Fukuda S, Seo Y, Shiomi H, Yamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K.

J Radiat Res. 2014 Nov;55(6):1114-21. doi: 10.1093/jrr/rru048.

7.

A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment.

Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1169-78. doi: 10.1016/j.ijrobp.2011.09.015.

8.

Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.

De Meerleer GO, Vakaet LA, De Gersem WR, De Wagter C, De Naeyer B, De Neve W.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):639-48.

PMID:
10837946
9.

A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.

Song DY, Herfarth KK, Uhl M, Eble MJ, Pinkawa M, van Triest B, Kalisvaart R, Weber DC, Miralbell R, Deweese TL, Ford EC.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):81-7. doi: 10.1016/j.ijrobp.2012.12.019.

10.

Experience-based quality control of clinical intensity-modulated radiotherapy planning.

Moore KL, Brame RS, Low DA, Mutic S.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):545-51. doi: 10.1016/j.ijrobp.2010.11.030.

PMID:
21277097
11.

A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.

Kole TP, Nichols RC, Lei S, Wu B, Huh SN, Morris CG, Lee S, Tong M, Mendenhall NP, Dritschilo A, Collins SP.

Acta Oncol. 2015 Jun;54(6):825-31. doi: 10.3109/0284186X.2014.953260.

PMID:
25227898
12.

Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.

Rijkhorst EJ, Lakeman A, Nijkamp J, de Bois J, van Herk M, Lebesque JV, Sonke JJ.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1254-60. doi: 10.1016/j.ijrobp.2009.04.034.

PMID:
19857789
13.

Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.

Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):534-41. doi: 10.1016/j.ijrobp.2013.06.2053.

PMID:
23972722
14.

Noncoplanar Beam Angle Class Solutions to Replace Time-Consuming Patient-Specific Beam Angle Optimization in Robotic Prostate Stereotactic Body Radiation Therapy.

Rossi L, Breedveld S, Aluwini S, Heijmen B.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):762-70. doi: 10.1016/j.ijrobp.2015.03.013.

PMID:
26104931
15.

Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization.

Schulze D, Liang J, Yan D, Zhang T.

Radiother Oncol. 2009 Mar;90(3):367-76. doi: 10.1016/j.radonc.2008.08.012.

16.

Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.

Wang L, Movsas B, Jacob R, Fourkal E, Chen L, Price R, Feigenberg S, Konski A, Pollack A, Ma C.

J Appl Clin Med Phys. 2004 Spring;5(2):29-41.

PMID:
15738911
17.

Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.

Murthy V, Shukla P, Adurkar P, Master Z, Mahantshetty U, Shrivastava S.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):119-24. doi: 10.1016/j.ijrobp.2011.11.001.

PMID:
22300567
18.

A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.

Shah AP, Chen SS, Strauss JB, Kirk MC, Coleman JL, Coon AB, Miller C, Dickler A.

Am J Clin Oncol. 2009 Oct;32(5):460-6. doi: 10.1097/COC.0b013e3181967d89.

PMID:
19564784
19.

Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.

Martinez AA, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M, Jaffray DA, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1226-34.

PMID:
11483333
20.

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.

Fuller DB, Naitoh J, Lee C, Hardy S, Jin H.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1588-97. doi: 10.1016/j.ijrobp.2007.11.067.

PMID:
18374232

Supplemental Content

Support Center